Deregulating Psychedelics Could Boost Clinical Studies
American researchers will be able to study various psychedelics and their effects on the human body much more effectively if hallucinogens are finally deregulated after decades of state and federal prohibition. Similar to how cannabis research opened up after dozens of states legalized either recreational or medical cannabis, policymakers hold the key to more comprehensive psychedelic clinical studies. Researchers typically have a significantly hard time accessing and researching controlled substances such as psychedelics, which makes them less inclined to research hallucinogenic drugs. However, with psychedelic use increasing across the country as more people turn to hallucinogens to alleviate their mental…
